122 related articles for article (PubMed ID: 29340013)
1. The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme.
Abbruzzese C; Catalogna G; Gallo E; di Martino S; Mileo AM; Carosi M; Dattilo V; Schenone S; Musumeci F; Lavia P; Perrotti N; Amato R; Paggi MG
Oncotarget; 2017 Dec; 8(67):110743-110755. PubMed ID: 29340013
[TBL] [Abstract][Full Text] [Related]
2. SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells.
Talarico C; Dattilo V; D'Antona L; Barone A; Amodio N; Belviso S; Musumeci F; Abbruzzese C; Bianco C; Trapasso F; Schenone S; Alcaro S; Ortuso F; Florio T; Paggi MG; Perrotti N; Amato R
Oncotarget; 2016 Mar; 7(13):15868-84. PubMed ID: 26908461
[TBL] [Abstract][Full Text] [Related]
3. The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells.
Matteoni S; Abbruzzese C; Matarrese P; De Luca G; Mileo AM; Miccadei S; Schenone S; Musumeci F; Haas TL; Sette G; Carapella CM; Amato R; Perrotti N; Signore M; Paggi MG
J Exp Clin Cancer Res; 2019 May; 38(1):202. PubMed ID: 31101126
[TBL] [Abstract][Full Text] [Related]
4. The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells.
Catalogna G; Talarico C; Dattilo V; Gangemi V; Calabria F; D'Antona L; Schenone S; Musumeci F; Bianco C; Perrotti N; Amato R; Cascini GL
Cell Physiol Biochem; 2017; 43(1):108-119. PubMed ID: 28848088
[TBL] [Abstract][Full Text] [Related]
5. Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy.
Talarico C; D'Antona L; Scumaci D; Barone A; Gigliotti F; Fiumara CV; Dattilo V; Gallo E; Visca P; Ortuso F; Abbruzzese C; Botta L; Schenone S; Cuda G; Alcaro S; Bianco C; Lavia P; Paggi MG; Perrotti N; Amato R
Oncotarget; 2015 Nov; 6(35):37511-25. PubMed ID: 26462020
[TBL] [Abstract][Full Text] [Related]
6. In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity.
D'Antona L; Dattilo V; Catalogna G; Scumaci D; Fiumara CV; Musumeci F; Perrotti G; Schenone S; Tallerico R; Spoleti CB; Costa N; Iuliano R; Cuda G; Amato R; Perrotti N
Transl Oncol; 2019 Aug; 12(8):1045-1055. PubMed ID: 31163384
[TBL] [Abstract][Full Text] [Related]
7. The small molecule SI113 hinders epithelial-to-mesenchymal transition and subverts cytoskeletal organization in human cancer cells.
Abbruzzese C; Matteoni S; Persico M; Ascione B; Schenone S; Musumeci F; Amato R; Perrotti N; Matarrese P; Paggi MG
J Cell Physiol; 2019 Dec; 234(12):22529-22542. PubMed ID: 31099037
[TBL] [Abstract][Full Text] [Related]
8. The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells.
Conza D; Mirra P; Calì G; Tortora T; Insabato L; Fiory F; Schenone S; Amato R; Beguinot F; Perrotti N; Ulianich L
J Cell Physiol; 2017 Dec; 232(12):3735-3743. PubMed ID: 28177128
[TBL] [Abstract][Full Text] [Related]
9. Modulation of miR-21 signaling by MPS1 in human glioblastoma.
Maachani UB; Tandle A; Shankavaram U; Kramp T; Camphausen K
Oncotarget; 2016 Aug; 7(33):52912-52927. PubMed ID: 25991676
[TBL] [Abstract][Full Text] [Related]
10. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
[TBL] [Abstract][Full Text] [Related]
11. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
12. Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation by inhibiting angiotensin-(1-7)/Mas signaling.
Liu B; Liu Y; Jiang Y
Oncol Rep; 2015 May; 33(5):2583-91. PubMed ID: 25708368
[TBL] [Abstract][Full Text] [Related]
13. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM).
Elkamhawy A; Viswanath AN; Pae AN; Kim HY; Heo JC; Park WK; Lee CO; Yang H; Kim KH; Nam DH; Seol HJ; Cho H; Roh EJ
Eur J Med Chem; 2015 Oct; 103():210-22. PubMed ID: 26355532
[TBL] [Abstract][Full Text] [Related]
15. FK506 confers chemosensitivity to anticancer drugs in glioblastoma multiforme cells by decreasing the expression of the multiple resistance-associated protein-1.
Garrido W; Muñoz M; San Martín R; Quezada C
Biochem Biophys Res Commun; 2011 Jul; 411(1):62-8. PubMed ID: 21708136
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
[TBL] [Abstract][Full Text] [Related]
17. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.
Elmaci İ; Altinoz MA
Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
[TBL] [Abstract][Full Text] [Related]
18. Designer therapies for glioblastoma multiforme.
Sathornsumetee S; Rich JN
Ann N Y Acad Sci; 2008 Oct; 1142():108-32. PubMed ID: 18990124
[TBL] [Abstract][Full Text] [Related]
19. The novel agent phospho-glycerol-ibuprofen-amide (MDC-330) inhibits glioblastoma growth in mice: an effect mediated by cyclin D1.
Bartels LE; Mattheolabakis G; Vaeth BM; LaComb JF; Wang R; Zhi J; Komninou D; Rigas B; Mackenzie GG
Carcinogenesis; 2016 Apr; 37(4):420-429. PubMed ID: 26905586
[TBL] [Abstract][Full Text] [Related]
20. Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.
Lee SJ; Kang WY; Yoon Y; Jin JY; Song HJ; Her JH; Kang SM; Hwang YK; Kang KJ; Joo KM; Nam DH
BMC Cancer; 2015 Dec; 15():1011. PubMed ID: 26704632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
